Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · Real-Time Price · USD
2.390
-0.070 (-2.85%)
Dec 27, 2024, 4:00 PM EST - Market closed
Akoya Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -57.97 | -63.32 | -70.64 | -42.94 | -16.71 | -14.75 |
| Depreciation & Amortization | 7.91 | 8.89 | 7.15 | 4.79 | 3.82 | 3.06 |
| Loss (Gain) From Sale of Assets | - | - | 0.08 | - | - | - |
| Loss (Gain) From Sale of Investments | -1.4 | -0.01 | -0.22 | - | - | - |
| Stock-Based Compensation | 9.72 | 10.44 | 7.43 | 4.04 | 0.48 | 0.15 |
| Other Operating Activities | 6.63 | 7.58 | 2.55 | 2.6 | 3.18 | -0.86 |
| Change in Accounts Receivable | 2.4 | -7.27 | -0.29 | -2.97 | 6.7 | -3.37 |
| Change in Inventory | -9.67 | -6.33 | -5.37 | -4.63 | -0.68 | -4.01 |
| Change in Accounts Payable | -3.13 | 1.15 | 1.19 | 4.36 | -3.05 | -0.05 |
| Change in Unearned Revenue | -0.35 | 1.49 | 2.58 | 0.96 | -0.43 | 3.23 |
| Change in Other Net Operating Assets | -4.72 | -3.52 | 2.04 | -2.28 | -0.15 | 2.82 |
| Operating Cash Flow | -46.71 | -50.9 | -53.5 | -36.07 | -6.84 | -13.78 |
| Capital Expenditures | -2.01 | -3.65 | -7.36 | -5.09 | -3.3 | -2.87 |
| Sale of Property, Plant & Equipment | - | - | 0.06 | - | - | - |
| Investment in Securities | -25.33 | 7 | -6.77 | - | 10.02 | -10.02 |
| Investing Cash Flow | -27.34 | 3.35 | -14.08 | -5.09 | 6.73 | -12.89 |
| Long-Term Debt Issued | - | 11.25 | 31.25 | - | 34.98 | 30 |
| Long-Term Debt Repaid | - | -0.68 | -0.62 | -0.32 | -25.19 | -25.04 |
| Net Debt Issued (Repaid) | 10.55 | 10.57 | 30.63 | -0.32 | 9.79 | 4.96 |
| Issuance of Common Stock | 0.08 | 48.31 | 0.45 | 138.95 | 0.12 | 0 |
| Repurchase of Common Stock | -0.21 | -0.09 | - | - | - | - |
| Other Financing Activities | -2.06 | -1.95 | -2.35 | -1.59 | -4.42 | -1.4 |
| Financing Cash Flow | 8.36 | 56.84 | 28.73 | 137.04 | 5.49 | 28.56 |
| Net Cash Flow | -65.69 | 9.29 | -38.85 | 95.87 | 5.37 | 1.89 |
| Free Cash Flow | -48.71 | -54.55 | -60.86 | -41.16 | -10.14 | -16.65 |
| Free Cash Flow Margin | -56.11% | -56.45% | -81.29% | -74.95% | -23.89% | -39.41% |
| Free Cash Flow Per Share | -0.99 | -1.23 | -1.61 | -1.53 | -4.28 | -7.31 |
| Cash Interest Paid | 8.91 | 7.65 | 3.48 | 2.67 | 2.25 | 1.79 |
| Cash Income Tax Paid | - | 0.06 | - | - | - | - |
| Levered Free Cash Flow | -28.61 | -34.04 | -34.24 | -26.04 | -5.5 | - |
| Unlevered Free Cash Flow | -22.28 | -28.56 | -31.39 | -24.1 | -3.8 | - |
| Change in Net Working Capital | 10.23 | 9.22 | -2.77 | 4.57 | -2.38 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.